A Prospective Multicentre Phase II Trial of Zoledronic Acid in Patients With Myelofibrosis With Myeloid Metaplasia (MMM).
Phase of Trial: Phase II
Latest Information Update: 23 Dec 2014
At a glance
- Drugs Zoledronic acid (Primary)
- Indications Myelofibrosis
- Focus Pharmacodynamics
- 01 Dec 2010 Status changed from recruiting to completed as reported by ClinicalTrials.gov.
- 27 Oct 2009 New trial record